PAHC
NASDAQ · Pharmaceuticals
Phibro Animal Health Corp-A
$50.76
-1.62 (-3.09%)
Performance
1D
—
1W
—
1M
—
3M
+32.98%
6M
+29.66%
1Y
+134.57%
YTD
+36.09%
Open$52.09
Previous Close$52.38
Day High$52.58
Day Low$49.89
52W High$56.30
52W Low$16.16
Volume—
Avg Volume280.4K
Market Cap2.09B
P/E Ratio22.67
EPS$2.26
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$42.00
Above
SMA 200
$35.40
Above
RSI (14)
80.2
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Sell
9 analysts
Price Target
+112.2% upside
Current
$50.76
$50.76
Target
$107.71
$107.71
$71.95
$107.71 avg
$157.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.34B | 1.21B | 1.31B |
| Net Income | 50.08M | 40.53M | 335.32M |
| Profit Margin | 3.7% | 3.5% | 25.7% |
| EBITDA | 161.93M | 138.33M | 482.41M |
| Free Cash Flow | — | — | 282.39M |
| Rev Growth | +11.2% | +11.2% | +2.9% |
| Debt/Equity | 2.52 | 2.52 | 0.38 |
Dividend
Dividend Yield0.92%
Annual Dividend$0.48
Payout Ratio40.3%
Frequencyquarterly
Ex-DividendApr 7, 2026
Pay DateApr 17, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |